Insider Activity of Hadas Nicole R.
Biography of Hadas Nicole R.
No biography is available at this moment.
No biography is available at this moment.
| 2024-05-13 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 12,016 0.0056% | $1.26 | $15,140 | +34.11% | |
| 2024-02-29 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 5,974 0.0032% | $1.58 | $9,439 | -7.28% | |
| 2024-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 7,411 0.0036% | $1.52 | $11,265 | -10.37% | |
| 2023-05-25 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 63,186 0.0346% | $1.22 | $77,270 | +3.31% | |
| 2023-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 13,034 0.0068% | $0.88 | $11,437 | +23.5% | |
| 2023-02-27 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 6,677 0.0036% | $0.81 | $5,430 | +38.48% | |
| 2022-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 14,507 0.0082% | $2.17 | $31,490 | -80.93% | |
| 2022-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 6,555 0.0036% | $2.15 | $14,125 | -81.02% | |
| 2021-04-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 1,060 0.0007% | $3.40 | $3,604 | -15.92% | |
| 2021-03-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 14,285 0.0094% | $3.40 | $48,513 | -14.84% | |
| 2020-02-28 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, Chief Legal Officer | 7,050 0.0054% | $8.70 | $61,335 | -34.16% | |
| 2017-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 15,606 0.0326% | $19.89 | $310,377 | -45.25% | |
| 2017-07-03 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,108 0.0065% | $14.26 | $44,313 | -0.51% | |
| 2017-04-03 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,112 0.0078% | $9.18 | $28,560 | +64.77% | |
| 2017-01-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,620 0.0097% | $10.49 | $37,976 | +33.14% | |
| 2016-10-01 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,112 0.0082% | $8.95 | $27,867 | +14.17% | |
| 2016-07-05 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,114 0.0082% | $7.47 | $23,251 | +21.67% | |
| 2016-04-04 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,112 0.0081% | $9.41 | $29,284 | -7.02% | |
| 2016-01-04 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 3,622 0.0096% | $12.28 | $44,478 | -32.72% | |
| 2015-10-02 | Sale | Akebia Therapeutics, Inc. AKBA | SVP, General Counsel, Sec. | 2,968 0.0099% | $8.67 | $25,720 | -11.81% |